- Home
- OPK
OPK
OPKO Health Inc.
as 02-21-2025 4:00pm EST
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
Upcoming Earnings Alert:
Get ready for potential market movements as OPKO Health Inc. OPK prepares to release earnings report on 27 Feb 2025.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 1.0B | IPO Year: | 1995 |
| Target Price: | $2.75 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.86 - $1.76 | Next Earning Date: | 02-27-2025 |
| Revenue: | $711,408,000 | Revenue Growth: | -17.94% |
| Revenue Growth (this year): | -19.89% | Revenue Growth (next year): | 0.00% |
Stock Insider Trading Activity of OPKO Health Inc. (OPK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Jan 28 '25 | Buy | $1.47 | 47,537 | $70,060.03 | 213,234,014 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Jan 17 '25 | Buy | $1.47 | 150,000 | $220,425.00 | 213,234,014 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Jan 15 '25 | Buy | $1.48 | 500,000 | $740,850.00 | 213,234,014 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Dec 13 '24 | Buy | $1.60 | 125,000 | $199,375.00 | 213,234,014 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Dec 11 '24 | Buy | $1.56 | 500,000 | $781,050.00 | 213,234,014 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 29 '24 | Buy | $1.53 | 199,072 | $305,376.45 | 213,234,014 |
Latest OPKO Health Inc. News
OPK Breaking Stock News: Dive into OPK Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
Insider Monkey
10 days ago
Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?
GlobeNewswire
a month ago
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Insider Monkey
a month ago
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential
MT Newswires
a month ago
Opko Health Insider Bought Shares Worth $740,850, According to a Recent SEC Filing
GlobeNewswire
a month ago
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Zacks
a month ago
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
Zacks
a month ago
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains
Compare OPK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPK OPKO Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.